v3.26.1
Supplemental Financial Information
12 Months Ended
Dec. 27, 2025
Supplemental Financial Information  
Supplemental Financial Information

Note 2—Supplemental Financial Information

Inventories

Inventories consisted of the following (in thousands):

  ​ ​ ​

2025

  ​ ​ ​

2024

Raw materials

$

181

$

379

Work in process

190

54

Finished goods

3,012

2,311

$

3,383

$

2,744

Property and Equipment, net

Property and equipment, net consisted of the following (in thousands):

2025

  ​ ​ ​

2024

Machinery and equipment

$

779

$

765

Computer equipment and software

1,780

1,761

Leasehold improvements

113

495

Furniture and fixtures

630

630

3,302

3,651

Less: accumulated depreciation and amortization

(3,002)

(3,134)

$

300

$

517

Substantially all our property and equipment are located within the United States as of December 27, 2025 and December 28, 2024.

Disaggregation of Net Sales

The following table shows disaggregated net sales by major source (in thousands):

  ​ ​ ​

2025

2024

Resales of third-party products

$

180,070

$

134,851

Sale of our modular memory subsystems

8,560

12,252

Total net sales

$

188,630

$

147,103

Net product sales by country presented below are based on the billing location of the customer (in thousands):

  ​ ​ ​

2025

  ​ ​ ​

2024

United States

$

11,223

$

19,741

People's Republic of China (1)

170,750

124,173

Other countries

6,657

3,189

Total net sales

$

188,630

$

147,103

(1)

People’s Republic of China (“PRC”) includes Hong Kong and Taiwan.

The PRC accounted for more than 10% of our net product sales for fiscal year 2025. The United States and the PRC accounted for more than 10% of our net product sales for fiscal year 2024.

Loss Per Share

The following table shows the computation of basic and diluted loss per share of common stock (in thousands, except per share data):

2025

2024

Net loss per share—basic and diluted:

Numerator:

Numerator: Net loss

$

(24,824)

$

(53,865)

Less: Deemed dividend on warrant modification

(590)

Net loss attributable to common stock

$

(25,414)

$

(53,865)

Denominator: Weighted-average basic shares outstanding - basic and diluted

286,638

259,904

Net loss per share - basic and diluted

$

(0.09)

$

(0.21)

No allocation of undistributed earnings to participating securities was performed for periods with net loss as such securities do not have a contractual obligation to share in our loss.

The table below sets forth potentially dilutive weighted average common share equivalents, consisting of shares issuable upon the exercise of outstanding stock options and warrants using the treasury stock method and the shares vesting of issuable upon RSUs. These potential weighted average common share equivalents have been excluded from the diluted net loss per share calculations above as their effect would be anti-dilutive (in thousands):

2025

2024

Weighted average common share equivalents

2,185

1,822

Cash Flow Information

The following table shows supplemental disclosures of cash flow information and non-cash financing activities (in thousands):

2025

  ​ ​ ​

2024

Supplemental disclosure of cash flow information:

Cash paid during the year for:

Interest

$

56

$

101

Income taxes

$

$

1

Supplemental disclosure of non-cash investing and financing activities:

Debt financing of insurance

$

537

$

500

Deemed dividend on warrant modification

$

590

$

Liquidity

We incurred net loss of $24.8 million for the year ended December 27, 2025 and $53.9 million for the year ended December 28, 2024. As of December 27, 2025, cash, cash equivalents and restricted cash were $42.1 million, total assets were $49.5 million, working capital deficit was ($6.4) million, and stockholders’ deficit was ($5.2) million. We believe our existing balance of cash and cash equivalents (including restricted cash balances), which totaled $42.1 million as of December 27, 2025, along with cash receipts from revenues, borrowing availability under the 2023 SVB Credit Agreement (see Note 3), proceeds raised from the June 2025 Offering and October 2025 Offering (see Notes 8), funds raised through the March 2025 Purchase Agreement (see Note 8) and other future debt and equity offerings and taking into account cash expected to be used in our operations, will be sufficient to meet our anticipated cash needs for at least the next 12 months. This belief reflects our current assessment of known trends and uncertainties that could affect near term liquidity, including the timing of cash effects from customer advance payments, fluctuations in borrowing base availability and letters of credit usage and market conditions that affect our ability to utilize the March 2025 Purchase Agreement. For the long term (i.e., beyond the next 12 months), based on our current plans and assumptions, we believe our sources of liquidity and access to capital will be adequate to meet our cash requirements as they come due, and we are not currently aware of material cash requirements beyond 12 months other than those described in the Notes to Consolidated Financial Statements.